Derivation and validation of a novel bleeding risk score for elderly patients with venous thromboembolism on extended anticoagulation

Thrombosis and Haemostasis
Eva SeilerD Aujesky

Abstract

Existing clinical scores do not perform well in predicting bleeding in elderly patients with acute venous thromboembolism (VTE). We sought to derive an easy-to-use clinical score to help physicians identify elderly patients with VTE who are at high-risk of bleeding during extended anticoagulation (>3 months). Our derivation sample included 743 patients aged ≥65 years with VTE who were enrolled in a prospective multicenter cohort study. All patients received extended anticoagulation with vitamin K antagonists. We derived our score using competing risk regression, with the time to a first major bleeding up to 36 months of extended anticoagulation as the outcome, and 17 candidate variables as predictors. We used bootstrapping methods for internal validation. Sixty-six (9%) patients suffered major bleeding. The clinical score is based on seven clinical factors (previous bleeding, active cancer, low physical activity, anemia, thrombocytopenia, antiplatelet drugs/NSAIDs, and poor INR control). Overall, 48% of patients were classified as low-risk, 37% as moderate-risk, and 15% as high-risk of bleeding. The rate of major bleeding was 1.4 events in low-risk, 5.0 events in moderate-risk, and 12.2 events per 100 patientyears in high-risk ...Continue Reading

References

Jun 5, 1998·Journal of General Internal Medicine·D A McMahanX H Zhou
Mar 13, 1999·Archives of Internal Medicine·P M KuijerH R Büller
Mar 13, 1999·Annals of Internal Medicine·A C JusticeJ A Berlin
Jun 29, 2000·JAMA : the Journal of the American Medical Association·T G McGinnW S Richardson
Apr 3, 2002·JAMA : the Journal of the American Medical Association·Mitchell K HigashiAllan E Rettie
Apr 3, 2002·Journal of Clinical Epidemiology·Fernie J A Penning-van BeestBruno H C Stricker
Aug 15, 2003·The New England Journal of Medicine·Clive KearonUNKNOWN Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators
Apr 22, 2005·Journal of Thrombosis and Haemostasis : JTH·S SchulmanUNKNOWN Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on T
Jun 1, 2005·The American Journal of Medicine·Drahomir AujeskyMark S Roberts
Jun 3, 2005·The New England Journal of Medicine·Mark J RiederAllan E Rettie
Feb 8, 2006·Annals of Internal Medicine·Brendan M Reilly, Arthur T Evans
Nov 14, 2006·Chest·Theresa I ShiremanEdward F Ellerbeck
Mar 21, 2007·Journal of Thrombosis and Haemostasis : JTH·I A NaessJ Hammerstrøm
Oct 2, 2007·Journal of Thrombosis and Thrombolysis·Scott Kaatz
Mar 17, 2010·Journal of Thrombosis and Haemostasis : JTH·C JakobssonD Aujesky
Jun 16, 2010·American Journal of Preventive Medicine·Kristen J MertzSteven N Blair
Jul 16, 2011·Journal of the American College of Cardiology·Margaret C FangDaniel E Singer
Jan 30, 2013·Journal of Thrombosis and Thrombolysis·Marie MéanDrahomir Aujesky
Jul 17, 2013·Journal of Thrombosis and Haemostasis : JTH·J M T HendriksenJ A H de Groot
Aug 22, 2014·Journal of General Internal Medicine·Waltraud LeissDrahomir Aujesky
Nov 19, 2014·Journal of Thrombosis and Haemostasis : JTH·Pascal M FreyDrahomir Aujesky

❮ Previous
Next ❯

Citations

Sep 19, 2020·Journal of Thrombosis and Thrombolysis·Covadonga Gómez-CuervoUNKNOWN RIETE Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.